Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MioPain study of methocarbamol + paracetamol dose regimens in acute low back pain
2021-000067-68Phase 4Terminated
- Sponsor
- Angelini Pharma
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methocarbamol and acetaminophen in acute nonspecific low back pain, sponsored by Angelini Pharma. Primary endpoint: Time to complete relief of pain. Started Aug 2021; status: terminated.
02
Drugs
methocarbamolacetaminophen
03
Conditions
acute nonspecific low back pain
Beyond the preview
Go deeper on 2021-000067-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000067-68.